Literature DB >> 6407761

In vitro production of immune interferon (IFN gamma) by murine spleen cells when different sensitizing antigens are used in vivo and in vitro.

M Saito, T Yamaguchi, T Ebina, M Koi, E Aonuma, H Usami, N Ishida.   

Abstract

OK-432, a killed preparation of Streptococcus pyogenes, as well as bacillus Calmette-Guérin (BCG) and Corynebacterium parvum are all known to induce immune interferon (IFN gamma) in mice. To examine the mechanisms of IFN gamma induction by OK-432, DDI mice were sensitized with various doses of OK-432, either by a single injection of a 1-mg dose or repeated injections of 0.1-mg doses given intraperitoneally. Spleen cells removed from the mice 7-9 days after the last injection produced high-titered IFN gamma (600-800 IU/ml) in vitro in the presence of 5 micrograms/ml of OK-432. In the absence of OK-432, however, in vitro IFN gamma production of sensitized spleen cells was quite limited. Moreover, when inducers of different antigenic entities such as serologically unrelated Streptococcus faecalis, Listeria monocytogenes, or Con A were added in vitro, instead of OK-432, to the OK-432-sensitized spleen cells, high-titered IFN gamma production also occurred. This may indicate that the signal required by T cells to produce IFN gamma in vitro need not necessarily be the same as that required to sensitize mouse macrophage in vivo. Once sensitized with OK-432, mice spleen cells continued to produce high-titered IFN gamma for more than 3 but less than 5 weeks.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407761     DOI: 10.1016/0008-8749(83)90293-9

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  9 in total

1.  Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation.

Authors:  M Saito; O Ichimura; M Kataoka; Y Moriya; K Ueno; Y Sugawara; M Nanjo; N Ishida
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Induction of activated natural killer cells from murine spleen cells primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.

Authors:  H Yamaue; M Katsumi; K Tabuse; Y Tabuse; K Kuribayashi; T Nishihara; K Saito
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  Induction of tumor growth inhibitory factor (TGIF) in human mononuclear cells by OK-432, a streptococcal preparation.

Authors:  M Katano; H Yamamoto; T Mizoguchi; T Hisatsugu
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

4.  Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.

Authors:  H Yamaue; H Tanimura; M Iwahashi; M Tani; T Tsunoda; K Tabuse; K Kuribayashi; K Saito
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Role of cell-mediated immunity in the resistance to experimental sporotrichosis in mice.

Authors:  A Shiraishi; K Nakagaki; T Arai
Journal:  Mycopathologia       Date:  1992-10       Impact factor: 2.574

6.  OK432 inhibits experimental hepatic metastasis of colon adenocarcinoma ACL-15 in F344 rats.

Authors:  F Sugimoto; K Tsukada; K Hatakeyama; K Yoshida; T Muto
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

7.  Inhibition of autoimmune diabetes in NOD mice with serum from streptococcal preparation (OK-432)-injected mice.

Authors:  H Seino; J Satoh; S Shintani; K Takahashi; X P Zhu; T Masuda; T Nobunaga; M Saito; Y Terano; T Toyota
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

8.  Characterization of mouse natural killer cell activating factor (NKAF) induced by OK-432: evidence for interferon- and interleukin 2-independent NK cell activation.

Authors:  O Ichimura; S Suzuki; Y Sugawara; T Osawa
Journal:  Br J Cancer       Date:  1984-07       Impact factor: 7.640

9.  The use of lipoteichoic acid (LTA) from Streptococcus pyogenes to induce a serum factor causing tumour necrosis.

Authors:  A Yamamoto; H Usami; M Nagamuta; Y Sugawara; S Hamada; T Yamamoto; K Kato; S Kokeguchi; S Kotani
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.